Introduction {#sec1-1}
============

*Panchakarma*, the unique therapies of *Ayurveda*, attract the attention of people for the treatment of various disorders and also for their preventive and promotive effect. With increase of awareness and global acceptance, it is the need of the hour to work on individual *Karma*, with different formulations for different diseases, in a scientific manner. Therefore, in the present study *Vamana Karma* has been selected for the treatment of *Ekakushtha* (psoriasis). *Vamana Karma* is the best therapy\[[@ref1]\] for the elimination of vitiated *Kapha Dosha* from all over the body through *Aamashaya* (stomach) by means of medically induced vomiting.

For the *Vamana Karma*, mainly *Madanaphala* is widely used, and the other *Vamaka* drugs and their formulations are not in usual practice. Apart from *Madanaphala*, five other drugs and in total 355 formulations are described in Charaka Samhita,\[[@ref2]\] one of them is *Krutavedhana Kalpa*, which indicates the selection of different drugs and formulations in accordance to the *Dosha, Dushya* (tissues), and disease. *Krutavedhana* is specifically mentioned for a *Gadha Dosha* condition, like *Kushtha, Pandu* (anemia), *Pliha Roga* (splenomegaly), *Shopha* (edema), *Gara Visha*,\[[@ref3]\] and so on. *Ekakushtha* has been taken for present study. *Ekakushtha* is one among the *Kshudra Kushtha* (minor skin diseases) with the dominance of *Kapha* and *Vata Dosha* in particular, and the *Rakta* (blood) is vitiated in general. *Ekakushtha* can be co-related with psoriasis. Thus, in the present study *Vamana Karma* has been conducted by *Madanaphala* and *Krutavedhana* in the patients of psoriasis.

Aims and objectives {#sec2-1}
-------------------

To assess the effect of *Krutavedhana* on *Vamana Karma*To compare the effect of *Madanaphala Pippali* and *Krutavedhana* *Yoga* on *Vamana Karma*To compare the effect of *Vamana Karma* performed by *Madanaphala Pippali* and *Krutavedhana* on the alleviation of the signs and symptoms of psoriasis.

Materials and Methods {#sec1-2}
=====================

The patients having classical signs and symptoms of *Ekakushtha* (psoriasis), as described in *Bruhatrayi*, were selected. A special proforma including all the etiological factors of *Kushtha* with *Dushti Lakshana* (signs and symptoms of vitiation) of *Dosha, Dushya, Srotasa* (channels), and so on, was designed for assessment of all the patients. The patients were thoroughly questioned and examined on the basis of the proforma. Ethical clearance and informed consent were obtained before conducting the trial.

Selection of patients {#sec2-2}
---------------------

Patients suffering from *Ekakushtha* were selected from the Outpatient Department (OPD) and the Inpatient Department (IPD) of the I.P.G.T. and R.A., Hospital, Jamnagar, irrespective of religion, sex, occupation, caste, and so forth.

Inclusion criteria {#sec2-3}
------------------

Age between 18 and 60 years*Ekakushtha* is diagnosed as per Ayurveda

Exclusion criteria {#sec2-4}
------------------

Age below 18 years and above 60 yearsPatients of, hypertension, tuberculosis, carcinoma, other life-threatening, and complicated diseases, and major systemic illnesses

Pathological investigation {#sec2-5}
--------------------------

Blood for Hemoglobin (HB), Total Count (TC), Differential Count (DC), Erythrocyte Sedimentation Rate (ESR)Routine and microscopic examination of urine

Biochemical investigation {#sec2-6}
-------------------------

Lipid profile, Fasting blood sugar (FBS)

### Grouping {#sec3-1}

Patients were randomly divided and studied under two Groups, namely, Group A and Group B, irrespective of religion, sex, occupation, caste, and the like.

**Group A**: In this group *Vamana Karma* was performed by *Madanaphala Pippali*. *Panchatikta Ghrita* was given as *Shamana*, after *Sansarjana Krama*.

**Group B**: In this group *Vamana Karma* was performed by *Krutavedhana*. *Panchatikta Ghrita* was given as *Shamana*, after *Sansarjana Krama*.

Procedure, drug, dose, and duration {#sec2-7}
-----------------------------------
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Properties of *Madanaphala* and *Krutavedhana* {#sec2-8}
----------------------------------------------

### Madanaphala {#sec3-2}

*Rasa*: *Kashaya, Madhura, Tikta, Katu*

*Guna*: *Laghu, Ruksha*

*Veerya*: *Ushna*

*Vipaka*: *Katu*

*Prabhava*: *Vamaka*

### Krutavedhana {#sec3-3}

Rasa: Tikta

Guna: Laghu, Ruksha, Tikshna

Veerya: Ushna

Vipaka: Katu

Prabhava: Ubhayatobhagahara

Internal *Shamana Yoga* {#sec2-9}
-----------------------

After the *Sansarjana Krama Panchatikta Ghrita* was given as *Shamana Yoga*, in both groups, in the dose of 20 ml, twice a day for 15 days.

### Follow-up {#sec3-4}

After *Shamana* *Yoga*, follow-up was done, for 30 days.

### Pathya -- Apathya (Dos and don'ts) {#sec3-5}

*Pathya* -- *Apathya* was advised to the patient as per the classics.

Criteria for Assessment {#sec1-3}
=======================

Assessment of *Vamana Karma* was done by observing the features of *Samyaka Yoga* (proper induction), *Ayoga* (inadequate induction), and *Atiyoga* (excessive induction), with *Antiki, Maniki, Laingiki*, and *Vaigiki Shuddhi*.Changes in signs and symptoms of psoriasis were assessed by a specially designed proforma.The effect on *Vamana Karma* and effect on psoriasis in both the groups were compared.Statistical tools: The results were compared by the paired 't' test and percentage-wise comparison between the two groups.

Scoring pattern {#sec2-10}
---------------

The scoring pattern was based on the scoring of National Psoriatic Foundation (NPF), for signs and symptoms of psoriasis and a special scoring pattern was adopted for certain signs and symptoms of *Ekakushtha*.
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Criteria for the assessment of overall effect of the therapies {#sec2-11}
--------------------------------------------------------------

Complete remission: 100% relief in the signs and symptomsMarked improvement: \> 76% relief in the signs and symptomsModerate Improvement: 51 -- 75% relief in the signs and symptomsImproved: 26 -- 50% relief in the signs and symptomsUnchanged: Below 25% relief in the signs and symptoms

Observations {#sec2-12}
------------

### General observations {#sec3-6}

A total of 30 patients were registered. Among them, in Group A -- 13 patients completed the treatment and two patients discontinued, and in Group B -- 14 patients completed the treatment and one patient left the treatment. Maximum number of patients, (40%) belonged to the age group of 36 -- 45 years, 66.67% were male, 93.33% were of Hindu religion, 76.67% were married, 60% belonged to the middle class, 36.68% had primary education, 33.33% were businessmen, and 56.67% were habituated to a vegetarian diet. Maximum number of patients, (56.67%) had regular bowel habits and 46.67% had *Madhyama Koshtha* (moderate bowel); 73.34% had *Madhura* (sweet), *Amla* (sour), *Lavana* (salt), *Rasa* (taste) dominancy in their diet. Fifty percent had a dietary pattern of *Vishamashana* (irregular pattern of diet) and 40% were addicted to tobacco.

### *Dashvidha Pariksha* (Tenfold method of examination) {#sec3-7}

Maximum (40%) of the patients had *Kapha-Vata Prakruti* (constitution) followed by *Pitta-Kapha Prakruti* in 30% of the patients. Seventy percent of the patients had *Madhyama Sara* (moderate tissue buildup) and *Pramana* (quantity), 50% patients were of *Pravara Satva* (superior mental power), and 60% of the patients had *Madhyama Abhyavarana* and *Jarana Shakti* (moderate capacity for intake and digestion of food).

### Nidaanaas {#sec3-8}

Maximum number of patients (83.33%) took *Viruddha Aahaara* (contradictory food),\[[@ref4]\] like milk + *Khichadi* (Indian food recipe prepared from rice and green gram) and 70% of the patients consumed Fast food and curd. *Divaswapna* (day sleep) was observed in maximum, (50%) of the patients, followed by *Ajirnashana* (food intake during the state of indigestion) in 30%, and *Shitoshna Vyatyas Sevana* (alternative hot and cold usage) in 26.67% of the patients. *Chinta* (worrying) was reported in 50% of the patients. Only one patient (3.33%) had positive family history of psoriasis.

### Rupa {#sec3-9}

Krishna *Aruna Varna*, *Kandu*, *Rukshataa, Mahaavaastu*, and *Matshyashakalopam* were found in 100% of the patients followed by *Asvedanam* in 86.66% of the patients. Nail involvement was present in 23.33% of the patients and joint involvement was found in 20% of the patients. Maximum number of patients, that is, 83.33% had *Vata Kapha* dominance and all the patients had *Twak* and *Rakta Dushti* (skin and blood vitiation). As for the signs of psoriasis, maximum (90%) of patients had a positive Auspitz\'s sign.\[[@ref5]\] The plaque variety of psoriasis was found in 83.33% of the patients. Maximum patients, (40%) had 91 -- 100% of skin area involvement and 26.67% patients had 10 -- 12 years chronicity. Maximum, (83.33%) of the patients reported winter season as the aggravating factor, followed by stress in 40% and smoking in 13.33% of the patients.

Review of *Vamana Karma* {#sec2-13}
------------------------

Maximum, (43.34%) of the patients had *Samyak Snigdha Lakshana* (features of proper internal oleation) on the seventh day of *Snehapana*. Average maximum dose of ghee was 216.3 ml, average minimum dose of ghee was 31.5 ml, and average total dose of ghee was 756.15 ml. The average quantity taken for *Aakanthapana* (stomach filled up to the throat) was 996 ml, while time taken for the *Aakanthapana* was 5.5 minutes. The average dose of *Madanaphala* was 6 g and the average dose of *Krutavedhana* was 5.9 g.

Average time taken for induction of the first *Vega* was 12 minutes in Group A, while it was 15.4 minutes (Avg.) in Group B. After administering *Vamana yoga*, self-induced and projectile Vega was observed in 38.46% of the patients in Group A and 50% of the patients in Group B. The average number of *Vega* was 5.46 in Group A, while it was 7.3 in Group B. Average number of *Upavega* (smaller bouts) was 8.53 in Group A, while it was 6.7 in Group B.

The average quantity of *Yashtimadhu Phanta* was 3.5 l in both groups. The average quantity of *Saindhavajala* (salt water) was 3.08 l in both groups.

The difference in average quantity of output and input was 0.48 l in Group A, while it was 0.06 l in Group B.

Clear *Pitta* appeared in 30.76% of the patients in Group A and 28.57% of the patients in Group B. In the *Pittanta Lakshana*, *Katu-Tiktaasyata* (spicy and bitter taste in mouth) was observed in 53.84% of the patients in Group A and 64.28% of the patients in Group B. *Galakantha Daha* (burning sensation in throat) was observed in 61.53% of the patients in Group A and 64.28% of the patients in Group B.

In *Samyaka Vamita Lakshana* (signs and symptoms of proper emesis):\[[@ref6]\] *Kale Pravruti* (timely expulsion) was observed in 69.23% of the patients in Group A and in 85.71% of the patients in Group B. *Yathakrama Doshadarshana* (expulsion of *Dosha* in order) was observed in 69.23% of the patients in Group A and in 78.51% of the patients in Group B.

*Pravara Shuddhi* was observed in 53.84% of the patients in Group A and in 71.42% of the patients in Group B.

Results {#sec1-4}
=======

Effect of therapy on laboratory investigations {#sec2-14}
----------------------------------------------

After completion of the treatment, there were no major changes observed in the Hb, TC, DC or ESR in both the groups.

After completion of the treatment, in Group A Serum Triglyceride decreased by 15.37% and in Group B by 12.68%; while HDL had increased by 10.01% in Group B and by 01.69% in group A, but it was statistically in significant.

After *Vamana Karma* in Group A, The relief was 34.61% in *Kandu*, 27.77% in *Matshyashakaopam*, 26.83% in *Krishna aruna varna*, 7.69% in *Rukshata*. Among them, relief in *Kandu, Matsyashakalopam*, and *Krishna Aruna Varna* was statistically highly significant. In other symptoms, the result was insignificant \[[Table 1](#T1){ref-type="table"}\].

###### 

Effect of therapy after *Vamana Karma* on the chief symptoms in Group A
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After *Vamana Karma* in Group B, the relief was 50% in *Kandu*, 40.74% in *Matsyashakalopam*, 30% in *Rukshata*, 20.69% in *Krishna Aruna Varna*, 3.57% in *Asvedanam*, and 8.82% in *Mahavastu*. Among them, relief in *Kandu, Matsyashakalopam*, and *Rukshata* was statistically highly significant. Relief in *Krishna Aruna Varna* was statistically significant. In other symptoms, the result was insignificant \[[Table 2](#T2){ref-type="table"}\].

###### 

Effect of therapy after *Vamana Karma* on chief symptoms in Group B
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After completion of treatment in Group A, The relief was 71.42% in *Kandu*, 70.37% in *Matsyashakalopam* (Scaling), 51.51% in *Rukshata*, 55.55% in *Krishna Aruna Varna*, 38.24% in *Mahavastu*, and 44% in *Asvedanam*. The result was highly significant in *Matsyashakalopam, Krishna Aruna Varna, Kandu*, and *Rukshata*. A significant result was found in *Asvedanam* and *Mahavastu* \[[Table 3](#T3){ref-type="table"}\].

###### 

Effect of therapy after complete treatment on chief symptoms (*Vamana* followed by *Shamana*) in Group A

![](Ayu-32-487-g005)

After completion of treatment in Group B, The relief was 77.35% in *Kandu*, 72.22% in *Matsyashakalopam*, 51.90% in *Krishna Aruna Varna*, 52.5% in *Rukshata*, 44% in *Asvedanam*, and 42.10% in *Mahavastu*. The result was highly significant in *Asvedanam, Matsyashakalopam, Krishna Aruna Varna, Kandu*, and *Rukshata*. Significant result was found in *Mahavastu* \[[Table 4](#T4){ref-type="table"}\].

###### 

Effect of therapy after complete treatment on chief symptoms (*Vamana* followed by *Shamana*) in Group B
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Overall effect of the therapy {#sec2-15}
-----------------------------

15.38% of the patients were completely cured in Group A, while none were completely cured in Group B.

7.69% of the patients had marked improvement in Group A, while 28.58% patients in Group B had marked improvement.

46.15% of the patients showed moderate improvement in Group A, while 21.42% of the patients in Group B showed moderate improvement.

23.07% of the patients showed improvement in Group A, while 35.71% patients in Group B showed improvement.

7.69% of the patients remained unchanged in Group A, while 14.29% of the patients in Group B remained unchanged.

Discussion {#sec1-5}
==========

Disease {#sec2-16}
-------

*Mahavastu, Matsyashakalopam, Krishna Aruna Varna, Kandu*, and *Rukshata* were found in 100% of the patients, which clearly indicates the similarity of *Ekakushtha* with psoriasis. Although *Ekakushtha* is considered as *Kshudra Kushtha*, in the present senerio psoriasis is one of the severe skin diseases, which is *Krichhra Saadhya* in the treatment.

*Nidanas* and *Samprapti* observed in the present study: *Nidanas* like *Shita-Ushna Vyatyasa Sevana, Stress, Bija Dosha* (genetic factor), and Environment may lead to *Dhatu Shaithilyata* (laxity of the tissues) in *Twak, Rakta, Mamsa* (muscular tissue), *Lasika* (fluid and lymph). *Viruddha Aahara*, that is, milk + *Khichadi*, fast food, curd, and *Maamsa Sevana* (meat intake) and *Divaswapna* also leads to vitiation of *Kapha* and *Rakta*. These vitiated *Doshas* reach the *Dushya* like *Twak* and so on, and result in *Sthana Samshraya Avastha* (accumulation at the site of the lesion) and then produce symptoms of *Ekakushtha*.\[[@ref7]\]

Drug {#sec2-17}
----

The drug *Krutavedhana* was taken for the study of *Vamana Karma*. There is no specific reference in the classics regarding the part of *Krutavedhana* that has to be used for *Vamana Karma*. One reference was found in *Nighantu Aadarsha*, regarding the use of its *Beeja*, and its dose is 20 to 30 grains (125 mg). Based on this, *Krutavedhana Beeja Churna* was selected for *Vamana Karma* in the present study. As per classical reference, it was given with *Saindhava* and *Madhu*, with the *Anupana* (vehicle) of *Yashtimadhu Phaanta*.

### Vamana Karma {#sec3-10}

Dose of *Vamana Yoga* - Average dose of *Madanaphala* was 6 g and the average dose of *Krutavedhana* was 5.9 g. Dose should be given according to the *Bala* (strength), *Prakriti, Dosha*, and *Koshtha* of the patient.

The dose of *Madanaphala* may be taken at 6, 7, and 8 g for *Mridu, Madhyama*, and *Krura Koshtha* (soft, moderate, and hard bowel), respectively. The dose of *Krutavedhana* may be taken at 5, 6 and 7 g for *Mridu, Madhyama*, and *Krura Koshtha*, respectively.

### Vaigiki (based on the number of bouts) {#sec3-11}

Time of First Vega - 12 minutes (Avg.) was taken for induction of the first *Vega* in Group A, while it was 15.4 minutes (Avg.) in Group B. This indicates that *Krutavedhana* took more time for induction of *Vamana Vega*.

Self-induced and projectile *Vega* was the main quality expected in the first Vega of *Vamana Karma*, which was found in 50% of the patients with *Krutavedhana*. It might be because it had more *Tikshana* and *Vamaka Prabhava* (strong emetic property).

More *Vega* induced by *Krutavedhana* and more *Upavega* induced by *Madanaphala* was observed. Although *Vega* depends on many things like, patient\'s intake, cooperation, *Satva*, and so on, from this data it can be stated that *Krutavedhana* produces more *Vega* in comparison to *Madanaphala*.

### Maniki (based on quantity) {#sec3-12}

As per the *Maniki* criteria *Hina Shuddhi* (mild cleansing) was observed in Group A and even *Hina Shuddhi* was not observed in Group B. Practically the difference in output and input was not found to be more than 500 ml, which is the lower side of *Hina Shuddhi* as per the *Maniki* criteria.

### Antiki (based on end point) {#sec3-13}

The clear greenish yellow *Pitta* that appeared in both the groups was nearly the same. Clear *Pittanta* may not be possible in all patients. *Pittanta Lakshana* is an indirect method to observe the *Pitta Nirgamana* (expulsion of bile). It was little more in Group B, may be because of more *Vega* observed in this group.

### Laingiki (based on sigs and symptoms) {#sec3-14}

*Samyaka Vamita Lakshanas* indicate the process of *Vamana* and the subjective feeling of the patients after *Vamana Karma*. It was observed to be slightly more in Group B, may be because of the greater number of *Vega* and *Pittanta Lakshana*.

*Pravara Shuddhi* was observed in 53.84% of the patients in Group A, while it was 71.42% in Group *B. Shuddhi* depends upon the *Antiki, Maniki, Laingiki*, and *Vaigiki* criteria. By this, it can be stated that *Krutavedhana* may produce better *Vamana Karma* in comparison to *Madanaphala*.

Effect of therapy after *Vamana Karma* on chief symptoms {#sec2-18}
--------------------------------------------------------

After the *Vamana Karma*, Group B showed better relief in *Matsyashakalopam, Kandu*, and *Rukshata*, because *Krutavedhana* was '*Atyartha Katu Tikshnoshna*'\[[@ref8]\] (excessive pungent hot and penetrating). On account of the *Gunas* by which it acts on *Gadha Dosha* and also by its *Kushthaghna Prabhava* (specific capacity against the skin diseases) it might have provided better relief for these symptoms. Both the groups showed nearly similar results in *Krishna Aruna Varna* because *Vamana Karma* eliminated the vitiated *Pitta* along with the *Kapha*, thereafter formation of *Prashasta* (proper) *Rasa Dhatus* took place, which might have reduced *Krishna Aruna Varna*. Both the groups showed no relief in *Asvedanam* and *Mahavastu*, because these features were indicative of a longstanding nature, severe pathology, and deeply involved the *Dhatus*. Only *Vamana Karma* or any other *Shodhana* (cleansing) might not be capable of relieving it, without the administration of *Shamana* drugs, for longer duration.

Effect of therapy after complete Treatment (Vamana followed by Shamana) on chief symptoms {#sec2-19}
-----------------------------------------------------------------------------------------

After complete treatment, both the groups showed almost similar effect on *Asvedanam, Mahavastu, Matsyashakalopam, Krishna Aruna Varna, Kandu*, and *Rukshata*. *Ekakushtha* is *Kapha Vata Pradhana Kushtha* and its line of treatment is '*Vamanam Shlaeshmottareshu Kushtheshu*'\[[@ref9]\] (emesis is best for *Kapha*-dominant skin diseases). Therefore, first *Vamana Karma* should be done to elinimate the vitiated *Kapha Dosha* along with *Pitta*. For the *Vata Dosha, Sneha* is indicated as '*Vatottareshu Sharpi*' (Ghee is best for Vata-dominant skin diseases) and after *Vamana*, *Snehapana* is also indicated in *Kushtha* as '*Snehasya Panam Ishtam Shuddhe Koshthe*' (internal oleation after cleansing).\[[@ref10]\] In this study after *Vamana Karma, Panchatikta Ghrita* was given as *Shamana Sneha*, which settled the *Vata*, residual *Pitta*, and also purified the *Rasa* and *Rakta*, by its *Tikta Rasa* (bitter taste) and *Kushthaghna* property. Thus, after complete treatment, both the groups showed nearly similar results.

Conclusion {#sec1-6}
==========

*Ekakushtha* is quite similar to psoriasis due to its maximum similarity in chief signs and symptoms.

*Beeja* is a useful part of *Krutavedhana* and in powder form; its dose is 5 to 7 g for *Vamana Karma*.

*Krutavedhana* has produced a good number of Vega, *Pittanta Lakshana*, and *Pravara Shuddhi* in a majority of patients.

*Madanaphala* is the best among all *Vamaka* drugs, but *Krutavedhana* shows a similar to higher effect on *Vamana Karma*, in terms of *Antiki, Maniki, Vaigiki*, and *Laingiki Shuddhi*.

*Vamana Karma* by *Krutavedhana* showed better relief in *Matsyashakalopam*, *Kandu*, and *Rukshata*, while *Madanphala* showed better relief in *Krishn Aruna Varna*.

After completion of treatment, both the groups showed almost similar effect on *Asvedanam, Matsyashakalopam, Kandu, Rukshata, Krishnaruna Varna*, and *Mahavastu*.

*Krutavedhana* may be taken as one of the best *Vamaka Dravya* for *Vamana Karma* in *Ekakushtha*.
